Our top pick for
Eagle Bancorp, Inc is a banks-regional business based in the US. Eagle Bancorp shares (EGBN) are listed on the NASDAQ and all prices are listed in US Dollars. Eagle Bancorp employs 515 staff and has a trailing 12-month revenue of around USD$318.8 million.
|Latest market close||USD$45.25|
|52-week range||USD$22.5798 - USD$47.8155|
|50-day moving average||USD$38.4038|
|200-day moving average||USD$32.0029|
|Wall St. target price||USD$38|
|Dividend yield||USD$0.88 (2.17%)|
|Earnings per share (TTM)||USD$3.939|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-09)||N/A|
|1 month (2020-12-18)||11.02%|
|3 months (2020-10-16)||53.34%|
|6 months (2020-07-17)||46.58%|
|1 year (2020-01-17)||-1.91%|
|2 years (2019-01-18)||-16.44%|
|3 years (2018-01-18)||61.1|
|5 years (2016-01-16)||N/A|
Valuing Eagle Bancorp stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Eagle Bancorp's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Eagle Bancorp's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Eagle Bancorp shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Eagle Bancorp's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.1255. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Eagle Bancorp's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||USD$318.8 million|
|Operating margin TTM||57.52%|
|Gross profit TTM||USD$336.7 million|
|Return on assets TTM||1.35%|
|Return on equity TTM||10.7%|
|Market capitalisation||USD$1.3 billion|
TTM: trailing 12 months
There are currently 559,757 Eagle Bancorp shares held short by investors – that's known as Eagle Bancorp's "short interest". This figure is 2.3% up from 547,100 last month.
There are a few different ways that this level of interest in shorting Eagle Bancorp shares can be evaluated.
Eagle Bancorp's "short interest ratio" (SIR) is the quantity of Eagle Bancorp shares currently shorted divided by the average quantity of Eagle Bancorp shares traded daily (recently around 143527.43589744). Eagle Bancorp's SIR currently stands at 3.9. In other words for every 100,000 Eagle Bancorp shares traded daily on the market, roughly 3900 shares are currently held short.
However Eagle Bancorp's short interest can also be evaluated against the total number of Eagle Bancorp shares, or, against the total number of tradable Eagle Bancorp shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eagle Bancorp's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Eagle Bancorp shares in existence, roughly 20 shares are currently held short) or 0.0209% of the tradable shares (for every 100,000 tradable Eagle Bancorp shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eagle Bancorp.
Find out more about how you can short Eagle Bancorp stock.
Dividend payout ratio: 21.96% of net profits
Recently Eagle Bancorp has paid out, on average, around 21.96% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Eagle Bancorp shareholders could enjoy a 2.17% return on their shares, in the form of dividend payments. In Eagle Bancorp's case, that would currently equate to about $0.88 per share.
While Eagle Bancorp's payout ratio might seem low, this can signify that Eagle Bancorp is investing more in its future growth.
Eagle Bancorp's most recent dividend payout was on 1 February 2021. The latest dividend was paid out to all shareholders who bought their shares by 7 January 2021 (the "ex-dividend date").
Eagle Bancorp's shares were split on a 11:10 basis on 29 May 2013. So if you had owned 10 shares the day before before the split, the next day you'd have owned 11 shares. This wouldn't directly have changed the overall worth of your Eagle Bancorp shares – just the quantity. However, indirectly, the new 9.1% lower share price could have impacted the market appetite for Eagle Bancorp shares which in turn could have impacted Eagle Bancorp's share price.
Over the last 12 months, Eagle Bancorp's shares have ranged in value from as little as $22.5798 up to $47.8155. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eagle Bancorp's is 1.1375. This would suggest that Eagle Bancorp's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Eagle Bancorp, Inc. operates as the bank holding company for EagleBank that provides commercial and consumer banking services primarily in the United States. It accepts business and personal checking, NOW, tiered savings, and money market accounts, as well as individual retirement, certificate of deposit, and investment sweep accounts; and time deposits. The company also offers various commercial and consumer lending products comprising commercial loans for working capital, equipment purchases, real estate lines of credit, and government contract financing; asset based lending and accounts receivable financing; construction and commercial real estate loans; business equipment financing; consumer home equity lines of credit, personal lines of credit, and term loans; consumer installment loans, such as auto and personal loans; personal credit cards; and residential mortgage loans. In addition, it provides online and mobile banking services; and other services, including cash management services, business sweep accounts, lock boxes, remote deposit captures, account reconciliation services, merchant card services, safety deposit boxes, and automated clearing house origination, as well as after-hours depositories and ATM services. Further, the company offers insurance products and services through a referral program, as well as investment advisory services. The company serves sole proprietors, small and medium-sized businesses, partnerships, corporations, non-profit organizations and associations, and individuals, as well as investors. As of December 31, 2019, it operated 20 banking offices comprising 6 in Suburban Maryland, 5 in the District of Columbia, and 9 in Northern Virginia. Eagle Bancorp, Inc. was founded in 1997 and is headquartered in Bethesda, Maryland.
Everything we know about the Cloopen Group Holding Limited IPO, plus information on how to buy in.
Everything we know about the Decipher Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Proterra IPO, plus information on how to buy in.
Everything we know about the Grab IPO, plus information on how to buy in.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Everything we know about the Terns Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Angion Biomedica Corp IPO, plus information on how to buy in.
Everything we know about the PurposeBuilt Brands Inc IPO, plus information on how to buy in.
Everything we know about the Vor Biopharma Inc IPO, plus information on how to buy in.
Everything we know about the LumiraDx Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.